Sanna M. Makela

Kantvik, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial.

Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial.

Journal: Infection
Published: May 09, 2025

The Effect of Bifidobacterium animalis subsp. lactis Bl-04 on Influenza A Virus Infection in Mice.

The Effect of Bifidobacterium animalis subsp. lactis Bl-04 on Influenza A Virus Infection in Mice.

Journal: Microorganisms
Published: September 11, 2023

The effect of probiotic Bifidobacterium lactis Bl-04 on innate antiviral responses invitro.

The effect of probiotic Bifidobacterium lactis Bl-04 on innate antiviral responses invitro.

Journal: Heliyon
Published: May 12, 2023

Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).

Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).

Journal: Brain, behavior, & immunity - health
Published: January 25, 2023

The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro.

The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro.

Journal: iScience
Published: August 30, 2021

Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial.

Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial.

Journal: British journal of clinical pharmacology
Published: October 12, 2020

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.

Journal: Nutrients
Published: March 02, 2020

Highly Pathogenic H5N1 Influenza A Virus Spreads Efficiently in Human Primary Monocyte-Derived Macrophages and Dendritic Cells.

Highly Pathogenic H5N1 Influenza A Virus Spreads Efficiently in Human Primary Monocyte-Derived Macrophages and Dendritic Cells.

Journal: Frontiers in immunology
Published: March 23, 2018

RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression.

RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression.

Journal: Journal of virology
Published: June 18, 2015

Efficient replication and strong induction of innate immune responses by H9N2 avian influenza virus in human dendritic cells.

Efficient replication and strong induction of innate immune responses by H9N2 avian influenza virus in human dendritic cells.

Journal: Virology
Published: July 10, 2014

Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells.

Novel avian influenza A (H7N9) virus induces impaired interferon responses in human dendritic cells.

Journal: PloS one
Published: January 02, 2014

TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells.

TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells.

Journal: Molecular immunology
Published: March 02, 2010
Showing 1-12 of 12

Last Updated: 09/26/2026